These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7519672)

  • 61. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.
    Kaul R; Rowland-Jones SL; Kimani J; Fowke K; Dong T; Kiama P; Rutherford J; Njagi E; Mwangi F; Rostron T; Onyango J; Oyugi J; MacDonald KS; Bwayo JJ; Plummer FA
    Immunol Lett; 2001 Nov; 79(1-2):3-13. PubMed ID: 11595284
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
    Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
    J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
    Rutebemberwa A; Currier JR; Jagodzinski L; McCutchan F; Birx D; Marovich M; Cox JH
    AIDS; 2005 Jul; 19(11):1165-72. PubMed ID: 15990569
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
    Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH
    J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.
    Lekutis C; Letvin NL
    J Virol; 1998 Jul; 72(7):5840-4. PubMed ID: 9621044
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
    De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W
    Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. B cell antigenic site mapping of HIV-1 glycoproteins.
    Neurath AR
    Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
    [No Abstract]   [Full Text] [Related]  

  • 72. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR; Strick N; Jiang S
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual.
    Lieberman J; Fabry JA; Fong DM; Parkerson GR
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):383-92. PubMed ID: 9075479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire.
    Jennes W; Vuylsteke B; Borget MY; Traore-Ettiegne V; Maurice C; Nolan M; Nkengasong JN; Kestens L
    J Infect Dis; 2004 Feb; 189(4):602-10. PubMed ID: 14767812
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract]   [Full Text] [Related]  

  • 77. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
    Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
    J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
    Krowka J; Stites D; Debs R; Larsen C; Fedor J; Brunette E; Düzgünes N
    J Immunol; 1990 Apr; 144(7):2535-40. PubMed ID: 1969450
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Roles of HIV-1 Env variable regions in viral neutralization and vaccine development.
    Pinter A
    Curr HIV Res; 2007 Nov; 5(6):542-53. PubMed ID: 18045110
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.